Events2Join

Diagnostic performance of 18F‑DCFPyL PET vs. 68Ga‑PSMA PET ...


Diagnostic performance of 68 Ga-PSMA-11 (HBED-CC) PET/CT in ...

In 801 of the 1007 patients (79.5%) at least one lesion characteristic of recurrent PCa was detected on 68Ga-PSMA-11 PET/CT. The patient-based ...

Study compares 18F-based PSMA radiotracers to [68Ga]Ga-PSMA-11

[18F]DCFPyL was assessed to be a suitable alternative to [68Ga]Ga-PSMA-11 in PCa diagnosis and staging due to its similar lesion uptake rate ...

[PDF] Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC ...

[18F]DCFPyL PET/CT provided a high image quality and visualized small prostate lesions with excellent sensitivity and represents a highly promising ...

Diagnostic performance of 18F‑DCFPyL PET vs. - ProQuest

Diagnostic performance of 18F‑DCFPyL PET vs. Ga‑PSMA PET/CT in patients with suspected prostate cancer: A systemic review and meta‑analysis · Full Text.

Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC ... - Scite

“…In metastatic PC patients, the diagnostic performance of both 18 F-DCFBC and 18 F-DCFPyL PET/CT was superior to that of standard ...

A comparison of the diagnostic performance of 18F-PSMA-1007 and ...

Fluorine-18-PSMA-1007 positron emission tomography/computed tomography (PET/CT) was performed on the same patient after 68Ga-PSMA-11 PET/CT had ...

Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for ...

In 10 of 14 patients (71 %), at least one lesion suspicious for prostate cancer tissue was detected in [68Ga]Ga-PSMA-HBED-CC PET/CT imaging and ...

Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of ...

Statistical heterogeneity and publication bias were found.Conclusion: The results suggest that 18F-DCFPyL PET/CT has a relatively high detection rate in BRPCa.

Diagnostic Accuracy of 18F-Prostate Specific Membrane Antigen ...

F-PSMA PET/CT used to stage or restage prostate cancer. Comparison: ➢. Reference standards. ○. Histopathology. ○.

18F-Fluciclovine Vs 68Ga-PSMA-11 Imaging for Prostate Cancer ...

However, 18F-fluciclovine is almost equivalent to 68Ga-PSMA-11 in detecting distant sites of prostate cancer,” he noted. “For most situations ...

an introduction to a new class of positron emission tomography (PET ...

showed that for a PSA range of 0.5–3.5 µg/L, the PSA-stratified sensitivity of 18F-DCFPyL significantly exceeded that of 68Ga-PSMA-11 (88% vs. 66%). Outside of ...

Phase 3, prospective, multicenter study (IAEA-PSMA study).

Also, treatment was modified based on PSMA results in 56.8% of patients. The 68Ga-PSMA PET/CT positivity was consistent and not statistically different among ...

Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron ...

Prostate-specific membrane antigen (PSMA)–targeted positron emission tomography (PET) offers high detection rates (DRs) and superior diagnostic ...

Learn About Diagnostic Performance for PYLARIFY®

While all PSMA PET imaging agents carry the risk of image misinterpretation, PYLARIFY has no additional specific warning for image misinterpretation in the ...

[18F]AlF-PSMA-11 PET in diagnosing prostate cancer: a head-to ...

For the head-to-head comparison of [18F]AlF-PSMA-11 PET and [68Ga]Ga-PSMA-11 PET, there were comparable tracer uptakes in those glands in head ( ...

Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed ...

Most patients (10/13) had more than 1 intrapro- static lesion on 18F-DCFPyL PET and/or MRI. ... cal trials, which used 68Ga-PSMA-11 or 18F-PSMA-1007.3,7. 18F- ...

Head-To-Head Comparison of 68 Ga-PSMA-11 PET/CT and 99m Tc ...

On a per-patient basis, the diagnostic performance of 68Ga-PSMA-11 PET/CT is superior to that of 99mTc-MDP BS for the detection of PCa bone metastases.

Detection Rate of 68Ga-PSMA PET/CT vs. mpMRI Targeted Biopsy ...

Abstract. Background/Aim: To evaluate the diagnostic accuracy of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed ...

The Performance of FDA-Approved PET Imaging Agents in ... - uu .diva

Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Re- lapsed Prostate Cancer. Mol. Imaging Biol ...